Here's an interesting take on the guy whose action prompted Hillary to trash the biotech sector: hwww.zerohedge.com/news/2015-09-22/following-public-fury-jim-cramer-trained-ceo-who-raised-price-drug-5000-agrees-lower "Many have speculated that the real goal of Shkreli's actions was to profit by shorting the biotech sector ahead of the selling which his action would have unleashed."
It's more populist posing from Hillary, unlikely to be enacted, but short-term it's a worry for some punters.
This user has not submitted any company ratings.
This user has not created any polls.